Healthcare and life sciences organisations have long operated in a competitive global environment, serving patients across borders but often remaining insulated from the geopolitical tensions affecting other industries. That era is coming to an end. As governments increasingly view healthcare through the lenses of national security, economic resilience and strategic autonomy, companies are facing new challenges around tariffs, supply chains, investment, market access, compliance and data governance.

In this briefing we explore the forces reshaping the sector and examine how businesses can build resilience, seize emerging opportunities and navigate an increasingly fragmented and uncertain global landscape.

Key takeaways

• The era of healthcare’s insulation from geopolitics is over, with tariffs, national security and industrial policy reshaping the sector worldwide.
• Companies are responding by localising manufacturing, diversifying supply chains and adopting more complex transaction structures to manage regulatory and political risk.
• As the policy and regulatory environment evolves, preparation, flexibility and vigilance will be critical for healthcare and life sciences businesses in the months and years ahead.